Cargando…
Nelfinavir: An Old Ally in the COVID-19 Fight?
After almost three years of the pandemic, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is still spreading around the world, causing notable sanitary and social issues. New antiviral therapies are constantly under investigation. However, few options have been approved for the treatmen...
Autores principales: | Gidari, Anna, Sabbatini, Samuele, Pallotto, Carlo, Bastianelli, Sabrina, Pierucci, Sara, Busti, Chiara, Schiaroli, Elisabetta, Francisci, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783559/ https://www.ncbi.nlm.nih.gov/pubmed/36557724 http://dx.doi.org/10.3390/microorganisms10122471 |
Ejemplares similares
-
Impact of SARS-CoV-2 Omicron variants on serum neutralization in a cohort of healthcare workers vaccinated with BNT162b2
por: Gidari, Anna, et al.
Publicado: (2022) -
Synergistic Activity of Remdesivir–Nirmatrelvir Combination on a SARS-CoV-2 In Vitro Model and a Case Report
por: Gidari, Anna, et al.
Publicado: (2023) -
Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected
por: Gidari, Anna, et al.
Publicado: (2021) -
The Combination of Molnupiravir with Nirmatrelvir or GC376 Has a Synergic Role in the Inhibition of SARS-CoV-2 Replication In Vitro
por: Gidari, Anna, et al.
Publicado: (2022) -
SARS-CoV-2 Survival on Surfaces and the Effect of UV-C Light
por: Gidari, Anna, et al.
Publicado: (2021)